Role of cholesteryl ester transfer protein in reverse cholesterol transport
- 1 February 1991
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 14 (S1) , 31-34
- https://doi.org/10.1002/clc.4960141305
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.Journal of Clinical Investigation, 1990
- Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver.Journal of Clinical Investigation, 1990
- Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.Journal of Clinical Investigation, 1990
- Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism.Journal of Clinical Investigation, 1989
- Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.Journal of Clinical Investigation, 1989
- Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of probucol-treated rabbitsThe American Journal of Cardiology, 1988
- Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particlesBiochemical and Biophysical Research Communications, 1987
- Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnoverAtherosclerosis, 1983
- Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesisAtherosclerosis, 1981